Inicio/Acciones/KMDA

KMDA

USD

Kamada Ltd. Ordinary Shares

$6.950+0.000 (0.000%)

Precio en Tiempo Real

Healthcare

Drug Manufacturers - Specialty & Generic

Israel

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$6.950

Máximo

$7.090

Mínimo

$6.930

Volumen

0.06M

Fundamentos de la Empresa

Capitalización de Mercado

403.0M

Industria

Drug Manufacturers - Specialty & Generic

País

Israel

Estadísticas de Negociación

Volumen Promedio

0.09M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $4.74Actual $6.950Máximo $9.15

Noticias Relacionadas

15 may 2025 · 14:39

Analyst Upgrades

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

Benchmark analyst Robert Wasserman reiterates Kamada with a Buy and maintains $15 price target.

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

7 may 2025 · 11:00

GlobeNewswire

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

5 may 2025 · 11:00

GlobeNewswire

Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in Collaboration with